Rapporto sull’analisi delle dimensioni e delle quote del mercato degli antibiotici | Previsioni 2031

  • Report Code : TIPRE00003406
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 161
Buy Now

Il mercato degli antibiotici è stato valutato a 44.111,31 milioni di dollari nel 2020 e si prevede che raggiungerà 59.253,24 milioni di dollari nel 2028; si prevede che crescerà a un CAGR del 4,0% nel corso del 2021-2028.

Gli antibiotici sono farmaci potenti utilizzati per combattere infezioni e malattie batteriche. Questi sono specificamente usati per trattare le infezioni causate da batteri come Staph., Strep. o E. coli. Gli antibiotici uccidono i batteri (battericidi) o ne impediscono la riproduzione e la crescita (batteriostatici). Il mercato degli antibiotici non funziona contro alcuna infezione virale. Alcune delle infezioni comuni trattate con antibiotici sono congiuntivite, infezione della pelle o dei tessuti molli, infezione del tratto respiratorio superiore, bronchite, faringite streptococcica (mal di gola) e tra le altre.

Mercati regionali redditizi di antibiotici


Approfondimenti di mercato

Crescente sviluppo di farmaci generici

Un medicinale generico è una copia di un farmaco di marca che non esiste più sotto brevetto. Le versioni generiche vengono introdotte sul mercato con l'obiettivo di offrire farmaci economicamente vantaggiosi e di aumentare la portata di questi farmaci a persone appartenenti a diverse classi economiche. Le versioni generiche sono popolari grazie alla loro disponibilità e convenienza. Ad esempio, secondo uno studio pubblicato sull’NCBI nel 2018, il prezzo medio di prescrizione del marchio era quasi 4 volte il prezzo medio del generico. Inoltre, le aziende si stanno concentrando anche sullo sviluppo di versioni generiche con l’obiettivo di offrire antibiotici a costi minimi. Ad esempio, nel giugno 2018, Lupin ha lanciato la soluzione inalatoria generica di tobramicina nel mercato statunitense. Inoltre, si prevede che l’incoraggiamento da parte delle autorità governative stimolerà la produzione di antibiotici generici, che alla fine guideranno la crescita del mercato degli antibiotici durante il periodo di previsione. Ad esempio, nel febbraio 2019, la Food and Drug Administration (FDA) statunitense ha annunciato l’approvazione per la commercializzazione di medicinali generici prodotti da aziende farmaceutiche indiane negli Stati Uniti.

Approfondimenti sul tipo di test

In base alla classe di farmaci, il mercato degli antibiotici è segmentato in sulfamidici, aminoglicosidi, carbapenemi, macrolidi, fluorochinoloni, penicillina, cefalosporine e altri. Il segmento delle cefalosporine ha detenuto la quota maggiore del mercato nel 2020; considerando che si prevede che il segmento dei fluorochinoloni registrerà il CAGR più elevato sul mercato durante il periodo di previsione.

Mercato globale degli antibiotici, per tipo di prodotto: 2020 e 2028


Approfondimenti sul meccanismo d'azione

In base al meccanismo d'azione, il mercato degli antibiotici è stato segmentato in inibitori dell'acido micolico e inibitori della sintesi dell'RNA , inibitori della sintesi del DNA, inibitori della sintesi proteica e inibitori della sintesi della parete cellulare. Il segmento degli inibitori della sintesi della parete cellulare ha detenuto la quota maggiore del mercato nel 2020, mentre si stima che il segmento degli inibitori della sintesi del DNA registrerà il CAGR più elevato sul mercato durante il periodo di previsione.

Approfondimenti strategici

Il lancio dei prodotti e le strategie di approvazione sono comunemente adottati dalle aziende per espandere la propria presenza e il portafoglio di prodotti in tutto il mondo e soddisfare la crescente domanda.

Gli operatori di mercato che operano nel mercato degli antibiotici adottano la strategia di espansione per ampliare la clientela base in tutto il mondo, che consente anche ai giocatori di mantenere il proprio marchio a livello globale. Ad esempio, nel luglio 2019, un'azienda come Pfizer ha lanciato un consorzio di ricerca internazionale per scoprire e sviluppare nuovi antibiotici per la tubercolosi in collaborazione con otto partner biotecnologici e accademici europei.

Il mercato globale degli antibiotici -; Per classe di farmaco

  • Cefalosporina
  • Penicillina
  • Fluorochinoloni
  • Macrolidi
  • Carbapenem
  • Aminoglicosidi
  • Sulfamidici
  • Altri

Mercato globale degli antibiotici - Per meccanismo d'azione

  • Inibitori della sintesi della parete cellulare
  • Inibitori della sintesi proteica
  • Inibitori della sintesi del DNA
  • Inibitori della sintesi dell'RNA
  • Inibitori dell'acido micolico
  • Altri

Antibiotici globali  – Per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto dell'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'Asia Pacifico
  • Medio Oriente e Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
    • Resto del Medio Oriente e dell'Africa
  • Sudamerica
    • Brasile
    • Argentina
    • Resto del Sud America

Profili aziendali

  • Pfizer, Inc
  • Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
  • Abbott,
  • GlaxoSmithKline Plc,
  • Sanofi,
  • Novartis AG,
  • Bayer AG,
  • Bristol Myers Squibb Company,
  • Eli Lilly and Company,
  • Astellas Pharma
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional analysis in terms of antibiotics?

The North American region holds the largest market for the breast cancer screening. The United States held the largest market for antibiotics market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer , growing developments for screening and imaging process by the companies and others.

What are the driving factors for antibiotics market across the globe?

The growth of the market is attributed to some key driving factors such as rising prevalence of bacterial infections, growing geriatric population and increasing development of generic drugs. However, tedious and expensive process of antibiotic development is expected to restraint the growth of the market during the forecast years.

What are antibiotics ?

Antibiotics are powerful medicines that are used to fight against bacterial infections. Antibiotics are also known as antibacterials which include a range of powerful drugs and are used to treat diseases caused by bacteria. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. and either kill the bacteria (bactericidal) or keep it from reproducing and growing (bacteriostatic). The antibiotics do not work against any viral infection. Some common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat) and among others.

The List of Companies - Antibiotics Market

  1. Pfizer, Inc
  2. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
  3. Abbott,
  4.  GlaxoSmithKline Plc,
  5. Sanofi,
  6.  Novartis AG,
  7.  Bayer AG,
  8. Bristol Myers Squibb Company,
  9. Eli Lilly and Company,
  10. Astellas Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports